ArticleDiabetes2016

A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice.

Ronald G Gill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.